A novel oridonin analogue, CYD0682, suppresses breast cancer growth, angiogenesis, and metastasis by inhibiting the ANGPTL4/MAPK signaling axis

Authors:
Open Access
Publisher website
Google Scholar
Abstract
No abstract available
Funding Information
  • Guangdong Pharmaceutical University (2024ZZ10)
  • Basic and Applied Basic Research Foundation of Guangdong Province (2023A1515010459)
  • University of Texas Medical Branch
  • Administration of Traditional Chinese Medicine of Jilin Province (20242048, 20251209)
  • Innovative Research Group Project of the National Natural Science Foundation of China

This publication has 5 references indexed in Scilit: